Multiple sclerosis and interferon β-1b, past, present and future

被引:5
作者
Horowski, R [1 ]
机构
[1] Schering AG, Med Sci Relat, D-13342 Berlin, Germany
关键词
pathogenesis; treatment; interferon; MRI;
D O I
10.1016/S0303-8467(02)00049-5
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:259 / 264
页数:6
相关论文
共 43 条
[1]   INTERFERONS AND MULTIPLE-SCLEROSIS [J].
ARNASON, BGW ;
REDER, AT .
CLINICAL NEUROPHARMACOLOGY, 1994, 17 (06) :495-547
[2]  
AUFDEMBRINKE B, 2001, NOVEL THERAPEUTIC PR, P129
[3]   T1 hypointense lesions in secondary progressive multiple sclerosis:: effect of interferon beta-1b treatment [J].
Barkhof, F ;
van Waesberghe, JHTM ;
Filippi, M ;
Yousry, T ;
Miller, DH ;
Hahn, D ;
Thompson, AJ ;
Kappos, L ;
Brex, P ;
Pozzilli, C ;
Polman, CH .
BRAIN, 2001, 124 :1396-1402
[4]  
Brueck Wolfgang, 2001, Multiple Sclerosis, V7, P173
[5]   Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b [J].
Dayal, AS ;
Jensen, MA ;
Lledo, A ;
Arnason, BGW .
NEUROLOGY, 1995, 45 (12) :2173-2177
[6]  
DUQUETTE P, 1995, NEUROLOGY, V45, P1277
[7]   INTERFERON BETA-1B IS EFFECTIVE IN RELAPSING-REMITTING MULTIPLE-SCLEROSIS - CLINICAL-RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
DUQUETTE, P ;
GIRARD, M ;
DESPAULT, L ;
DUBOIS, R ;
KNOBLER, RL ;
LUBLIN, FD ;
KELLEY, L ;
FRANCIS, GS ;
LAPIERRE, Y ;
ANTEL, J ;
FREEDMAN, M ;
HUM, S ;
GREENSTEIN, JI ;
MISHRA, B ;
MULDOON, J ;
WHITAKER, JN ;
EVANS, BK ;
LAYTON, B ;
SIBLEY, WA ;
LAGUNA, J ;
KRIKAWA, J ;
PATY, DW ;
OGER, JJ ;
KASTRUKOFF, LF ;
MOORE, GRW ;
HASHIMOTO, SA ;
MORRISON, W ;
NELSON, J ;
GOODIN, DS ;
MASSA, SM ;
GUTTERIDGE, E ;
ARNASON, BGW ;
NORONHA, A ;
REDER, AT ;
MARTIA, R ;
EBERS, GC ;
RICE, GPA ;
LESAUX, J ;
JOHNSON, KP ;
PANITCH, HS ;
BEVER, CT ;
CONWAY, K ;
WALLENBERG, JC ;
BEDELL, L ;
VANDENNOORT, S ;
WEINSHENKER, B ;
WEISS, W ;
REINGOLD, S ;
PACHNER, A ;
TAYLOR, W .
NEUROLOGY, 1993, 43 (04) :655-661
[8]   Interferon-β dose and efficacy:: the OPTIMS study [J].
Durelli, L ;
Oggero, A ;
Verdun, E ;
Barbero, P ;
Pipieri, A ;
Isoardo, G ;
Ricci, A ;
Clerico, M ;
Bradac, G ;
Bergamasco, B ;
Bergui, M .
NEUROLOGICAL SCIENCES, 2001, 22 (02) :201-203
[9]   Interferon-β1b in the treatment of secondary progressive MS -: Impact on quality of life [J].
Freeman, JA ;
Thompson, AJ ;
Fitzpatrick, R ;
Hutchinson, M ;
Miltenburger, C ;
Beckmann, K ;
Dahlke, F ;
Kappos, L ;
Polman, C ;
Pozzilli, C .
NEUROLOGY, 2001, 57 (10) :1870-1875
[10]  
Horowski R, 2001, FUNCT NEUROL, V16, P117